Should splenectomy be performed in an adult with a through-and-through iatrogenic splenic injury from chest tube insertion who is tachycardic but normotensive and has no coagulopathy, severe comorbidities, or peritoneal signs?

Management of Iatrogenic Through-and-Through Splenic Injury in a Tachycardic, Normotensive Patient

Do not proceed immediately to splenectomy in this tachycardic but normotensive patient with an iatrogenic through-and-through splenic injury—attempt non-operative management (NOM) with close monitoring and angioembolization if available, reserving surgery only for hemodynamic instability or NOM failure. 1

Hemodynamic Status Assessment

Your patient is not truly hemodynamically unstable despite the tachycardia:

• Hemodynamic instability requires systolic BP < 90 mmHg with altered consciousness, respiratory distress, or need for vasopressors/ongoing transfusions 2
• Tachycardia alone with maintained blood pressure represents a compensatory response, not frank instability 3
• The shock index (HR/SBP) is the critical metric—values > 1.0 indicate true instability 3
• Your patient is normotensive, which places them in the "stable or stabilized" category suitable for NOM 1

Absolute Indications for Immediate Splenectomy

Proceed to immediate operative management only if any of these are present:

• Unresponsive hemodynamic instability despite resuscitation (SBP persistently < 90 mmHg) 1
• Peritonitis on examination 1
• Hollow viscus injury requiring laparotomy 1
• Ongoing blood loss requiring continuous transfusion (>4 units of blood or 40 mL/kg within 24 hours) 1
• Failure of NOM with deteriorating clinical status 2

None of these appear to be present in your patient based on the scenario described.

Recommended Management Algorithm

Step 1: Immediate Actions

• Obtain contrast-enhanced CT scan to define the exact injury grade and identify associated injuries 1
• Establish intensive monitoring in ICU/high-dependency unit with continuous vital signs and serial hematocrit measurements 2
• Ensure immediate availability of operating room, blood products, and interventional radiology 2

Step 2: Risk Stratification

Your patient has a through-and-through injury, which likely represents a high-grade (Grade III-V) injury. Key risk factors for NOM failure include:

• Age > 55 years (strongest predictor) 1
• High injury severity score (ISS) 1
• Moderate to severe splenic injuries (Grade III-V) 1
• Contrast blush on CT (active extravasation) 2

Step 3: Angioembolization Decision

Strongly consider angiography/angioembolization (AG/AE) as first-line intervention if the patient remains hemodynamically stable:

• AG/AE is recommended for hemodynamically stable patients with arterial blush on CT, irrespective of injury grade 1
• AG/AE achieves spleen-salvage rates > 85% when vascular injury is identified 2
• Contrast blush predicts NOM failure in > 60% of cases without intervention 2
• Even high-grade injuries without blush benefit from AG/AE 2

Step 4: Monitoring Protocol During NOM

• Serial hematocrit every 4-6 hours initially 2
• Continuous hemodynamic monitoring with hourly vital signs 2
• Clinical examination for peritoneal signs every 2-4 hours 2
• Repeat CT imaging if hematocrit drops, hemodynamics worsen, or vascular anomalies persist 4, 2

Step 5: Conversion to Surgery

Convert to splenectomy if:

• Development of hemodynamic instability despite resuscitation 2
• Significant hematocrit decline requiring ongoing transfusion 2
• Failure of AG/AE with persistent bleeding 2
• Emergence of peritonitis 2

Critical Nuances and Pitfalls

The Tachycardia Issue

Tachycardia alone is NOT an absolute contraindication to NOM:

• Hemodynamic status at admission has not been considered a significant prognostic indicator for NOM failure in multiple studies 1
• Blood pressure maintenance is more important than heart rate 1
• However, this patient requires more intensive monitoring given the compensatory tachycardia 1

Iatrogenic vs. Traumatic Injury

While the guidelines primarily address traumatic splenic injury, the same principles apply to iatrogenic injury:

• The injury mechanism (iatrogenic vs. blunt trauma) is less important than hemodynamic status and injury grade 1
• Through-and-through injury suggests significant parenchymal disruption requiring aggressive management 2

Advantages of NOM Over Immediate Splenectomy

Attempting NOM first (when safe) offers significant benefits:

• Lower hospital costs and shorter length of stay 1
• Avoidance of non-therapeutic laparotomy 1
• Lower rates of intra-abdominal complications 1
• Lower mortality 1
• Preservation of immunological function and prevention of overwhelming post-splenectomy infection (OPSI) 1
• NOM success rates approach 90% in high-volume centers with appropriate resources 1

When NOM is Contraindicated

Do NOT attempt NOM if:

• Your facility lacks 24/7 interventional radiology capability 2
• ICU monitoring is unavailable 2
• Operating room cannot be mobilized immediately 2
• Blood products are not immediately available 2
• In these scenarios, transfer to a higher-level trauma center or proceed directly to splenectomy 1

Special Considerations

VTE Prophylaxis

• Initiate mechanical prophylaxis (intermittent pneumatic compression) immediately—safe even in high-grade injuries 2
• Start low-molecular-weight heparin 24-48 hours after bleeding control 2
• Angioembolization increases VTE risk (DVT rate 4.5% vs. 1.4% without embolization) 5
• Delaying chemical prophylaxis beyond 72 hours increases VTE rates more than fourfold 2

Splenic Preservation During Surgery

If you ultimately proceed to surgery, attempt splenic preservation:

• Partial (subtotal) splenectomy or splenorrhaphy should be attempted whenever technically feasible 1
• These techniques are safe even in high-grade injuries 1
• Total splenectomy should be reserved for uncontrollable bleeding 1

Expected Timeline

• NOM failure peaks at 4 hours, then declines over 36 hours 1
• 72.5% of NOM failures occur within the first week, with 50% in the first 3-5 days 1
• Delayed rupture can occur between days 4-10 post-injury 4, 2